SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277504
Filing Date
2023-11-15
Accepted
2023-11-15 06:16:01
Documents
13
Period of Report
2023-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850591d8k.htm   iXBRL 8-K 34493
2 EX-99.1 d850591dex991.htm EX-99.1 21126
  Complete submission text file 0001193125-23-277504.txt   193044

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20231115.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20231115_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20231115_pre.xml EX-101.PRE 11700
7 EXTRACTED XBRL INSTANCE DOCUMENT d850591d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 231408974
SIC: 2836 Biological Products, (No Diagnostic Substances)